Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) ยท filed Aug 8, 2022

Accession no.
0001209191-22-044703
Filed
Aug 8, 2022, 8:05 AM ET
Trade date
Aug 5, 2022
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 22 non-derivative transactions. Open-market purchases total $802.1K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 5, 2022Common StockPPurchaseAcquired+300$2.25+$673.5196,606,994Indirect
Aug 5, 2022Common StockPPurchaseAcquired+7,350$2.25+$16,537.5196,614,344Indirect
Aug 5, 2022Common StockPPurchaseAcquired+400$2.26+$902196,614,744Indirect
Aug 5, 2022Common StockPPurchaseAcquired+1,600$2.26+$3,614.4196,616,344Indirect
Aug 5, 2022Common StockPPurchaseAcquired+9,869$2.26+$22,303.94196,626,213Indirect
Aug 5, 2022Common StockPPurchaseAcquired+700$2.27+$1,585.5196,626,913Indirect
Aug 5, 2022Common StockPPurchaseAcquired+400$2.27+$908196,627,313Indirect
Aug 5, 2022Common StockPPurchaseAcquired+300$2.27+$681.03196,627,613Indirect
Aug 5, 2022Common StockPPurchaseAcquired+500$2.27+$1,136.25196,628,113Indirect
Aug 5, 2022Common StockPPurchaseAcquired+49,249$2.28+$112,041.48196,677,362Indirect
Aug 5, 2022Common StockPPurchaseAcquired+27,700$2.28+$63,156196,705,062Indirect
Aug 5, 2022Common StockPPurchaseAcquired+35,734$2.29+$81,652.19196,740,796Indirect
Aug 5, 2022Common StockPPurchaseAcquired+24,400$2.29+$55,876196,765,196Indirect
Aug 5, 2022Common StockPPurchaseAcquired+52,210$2.30+$119,821.95196,817,406Indirect
Aug 5, 2022Common StockPPurchaseAcquired+600$2.30+$1,378.5196,818,006Indirect
Aug 5, 2022Common StockPPurchaseAcquired+2,364$2.30+$5,433.42196,820,370Indirect
Aug 5, 2022Common StockPPurchaseAcquired+3,500$2.30+$8,046.5196,823,870Indirect
Aug 5, 2022Common StockPPurchaseAcquired+69,986$2.30+$160,967.8196,893,856Indirect
Aug 5, 2022Common StockPPurchaseAcquired+11,375$2.31+$26,219.38196,905,231Indirect
Aug 5, 2022Common StockPPurchaseAcquired+804$2.31+$1,857.24196,906,035Indirect
Aug 5, 2022Common StockPPurchaseAcquired+43,656$2.32+$101,063.64196,949,691Indirect
Aug 5, 2022Common StockPPurchaseAcquired+7,003$2.32+$16,246.96196,956,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)